September 22, 2022
Via: Medical Device NetworkNon-invasive, blood-based liquid biopsy tests have long been touted as the future for cancer diagnostics, but studies presented at the recent European Society for Medical Oncology (ESMO) Congress 2022, highlight the challenges remaining before they can reach routine clinical practice. […]
September 5, 2017
Via: ScienceDaily HealthEven small tumours can be aggressive, according to a study in patients with early stage breast cancer that will be presented at the ESMO 2017 Congress in Madrid. Researchers found that nearly one in four small tumours were aggressive and […]
March 28, 2024
April 19, 2024